Emerging Infectious Diseases (Apr 2018)

Seroprevalence of Chikungunya Virus after Its Emergence in Brazil

  • Juarez P. Dias,
  • Maria da Conceição N. Costa,
  • Gubio Soares Campos,
  • Enny S. Paixão,
  • Marcio S. Natividade,
  • Florisneide R. Barreto,
  • Martha Suely C. Itaparica,
  • Cristina Goes,
  • Francisca L.S. Oliveira,
  • Eloisa B. Santana,
  • Neusa S.J. Silva,
  • Carlos A.A. Brito,
  • Laura C. Rodrigues,
  • Silvia Inez Sardi,
  • Ramon C. Saavedra,
  • Maria Glória Teixeira

DOI
https://doi.org/10.3201/eid2404.171370
Journal volume & issue
Vol. 24, no. 4
pp. 617 – 624

Abstract

Read online

Chikungunya has had a substantial impact on public health because of the magnitude of its epidemics and its highly debilitating symptoms. We estimated the seroprevalence, proportion of symptomatic cases, and proportion of chronic form of disease after introduction of chikungunya virus (CHIKV) in 2 cities in Brazil. We conducted the population-based study through household interviews and serologic surveys during October–December 2015. In Feira de Santana, we conducted a serologic survey of 385 persons; 57.1% were CHIKV-positive. Among them, 32.7% reported symptoms, and 68.1% contracted chronic chikungunya disease. A similar survey in Riachão do Jacuípe included 446 persons; 45.7% were CHIKV-positive, 41.2% reported symptoms, and 75.0% contracted the chronic form. Our data confirm intense CHIKV transmission during the continuing epidemic. Chronic pain developed in a high proportion of patients. We recommend training health professionals in management of chronic pain, which will improve the quality of life of chikungunya-affected persons.

Keywords